The development of ovarian cancer involves alterations in multiple signaling pathways and genes, including AKT1, WNT/β-catenin, mTOR, Notch, ERK/Ras, p53, and c-Myc16-21. This evidence concerns the gene TP53 and ovarian carcinoma.